CorrlensCorrlens
Correlate

Correlation Analysis

Johnson & Johnson vs Revolution Medicines, Inc. Common Stock

JNJ vs RVMD

+0.688

Strong positive

When one moves up, the other tends to follow.

JNJ logo

Johnson & Johnson

JNJ

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Market cap 580.4B

RVMD logo

Revolution Medicines, Inc. Common Stock

RVMD

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Market cap 18.9B · 883 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: JNJGray: RVMD36 of 1,254 points (sampled)

Who Moves First

in sync

JNJ and RVMD tend to move at the same time.

After testing 13 timing shifts, the strongest relationship was +0.688 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.582

11 periods · Return correlation when both series rose

Both Falling

+0.370

7 periods · Return correlation when both series fell

Diverging

-0.662

17 periods · Return correlation when series moved apart

R-Squared

47.3%

Share of variance in one series explained by the other.

Trend Agreement

53.4%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.657, 0.716]

Scatter

XY Regression

135.5140160180200220240252.69.420406080100103.8Johnson & JohnsonRevolution Medicines, Inc. Common StockData pointsFit (r = 0.688)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

JNJ logo

Johnson & Johnson

JNJ

Market cap 580.4B

Stock · 1,254 raw → 1,254 prepared

Series B

RVMD logo

Revolution Medicines, Inc. Common Stock

RVMD

Market cap 18.9B · 883 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

69

Estimated crossover points between normalized spreads.

Slope

0.6795

Linear regression slope.

Intercept

-78.1231

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 7 hours ago · ID: stock-jnj-vs-stock-rvmd-daily